The characteristics of these cell lines are listed in Table W1. BO-1509 (3-(4-methoxyphenyl)-9H-pyrrolo[1,2-a]indole-1,2-diyl)bis(methylene) bis(ethylcarbamate) was synthesized as previously described www.selleckchem.com/products/ABT-888.html [28]. The PI3K inhibitor LY294002 was purchased from Cayman Chemical Company (Ann

Arbor, MI). For the cytotoxicity assays, 3000 cells were seeded into each well of a 96-well plate, incubated overnight at 37°C, and then treated for 72 hours with various concentrations of BO-1509, LY294002, or a combination of both compounds. At the end of the treatment, 20 μl of Alamar Blue solution (AbD Serotec, Kidlington, United Kingdom) was added to each well and then incubated for 6 hours. Cell viability was assessed by measuring the absorbance at 570

and 600 nm according to the manufacturer’s instructions. The concentration of drug that resulted in a 50% inhibition of cell growth (IC50) was determined for each drug, and the combination index (CI) was determined using the CompuSyn software (version 1.0.1; CompuSyn, Inc, Paramus, NJ) and the median effect principle and plot [43]. The IC50 values were presented as means ± SD of three independent experiments. Western blot analysis MK-1775 solubility dmso was performed as previously described [29] and was adopted to determine the intracellular protein levels in response to drug treatment. Briefly, cells were harvested after drug treatment and lysed in electrophoresis sample

buffer. Proteins were then electrophoretically separated on a sodium dodecyl sulfate–polyacrylamide gel and transferred onto polyvinylidene difluoride membranes (Amersham Biosciences, GE Healthcare Bio-Sciences Corp, Piscataway, NJ). Protein-conjugated membranes were incubated with primary antibodies overnight at 4°C and then incubated with HRP-conjugated anti-rabbit or anti-mouse secondary antibody for 1 hour at room temperature. Western blot signals were visualized by chemiluminescence using SuperSignal West Pico chemiluminescence reagent (Pierce, Rockford, IL). Antibodies against AKT, phospho-AKT, Mre11, and FANCD2 were obtained Org 27569 from Santa Cruz Biotechnology (Dallas, TX), whereas antibodies against Nbs1, phospho-Nbs1 (pNbs1), Rad50, Rad51, and β-actin were from Genetex (San Antonio, TX). Antibodies against caspase-3, caspase-7, and poly(ADP-ribose) polymerase (PARP) and secondary antibodies against rabbit and mouse Ig were purchased from Cell Signaling Technology (Danver, MA). The anti-γH2AX antibody was obtained from Millipore (Billerica, MA). The induction of apoptosis by the treatment of cells with BO-1509, LY294002, or a combination of both agents was detected by flow cytometry using 4′,6-diamidino-2-phenylindole (DAPI) staining (1 μg/ml; Merck Millipore, Darmstadt, Germany) and the Annexin V–FITC Apoptosis Detection Kit (Calbiochem, La Jolla, CA) according to the manufacturer’s instructions.